An Official ATS/ERS/ESICM/SCCM/SRLF Statement: Prevention and Management of Acute Renal Failure in the ICU Patient An International Consensus Conference in Intensive Care Medicine

被引:191
作者
Brochard, Laurent
Abroug, Fekri
Brenner, Matthew
Broccard, Alain F.
Danner, Robert L.
Ferrer, Miquel
Laghi, Franco
Magder, Sheldon
Papazian, Laurent
Pelosi, Paolo
Polderman, Kees H.
机构
关键词
CRITICALLY-ILL PATIENTS; CONTINUOUS VENOVENOUS HEMOFILTRATION; CONTRAST-INDUCED NEPHROPATHY; ACUTE KIDNEY INJURY; ABDOMINAL COMPARTMENT SYNDROME; HEPARIN-INDUCED THROMBOCYTOPENIA; HIGH-VOLUME HEMOFILTRATION; PERCUTANEOUS CORONARY INTERVENTION; ACUTE CONTINUOUS HEMODIAFILTRATION; ATRIAL-NATRIURETIC-PEPTIDE;
D O I
10.1164/rccm.200711-1664ST
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To address the issues of Prevention and Management of Acute Renal Failure in the ICU Patient, using the format of an International Consensus Conference. Methods and Questions: Five main questions formulated by scientific advisors were addressed by experts during a 2-day symposium and a Jury summarized the available evidence: (1) Identification and definition of acute kidney insufficiency (AKI), this terminology being selected by the Jury; (2) Prevention of AKI during routine ICU Care; (3) Prevention in specific diseases, including liver failure, lung Injury, cardiac surgery, tumor lysis syndrome, rhabdomyolysis and elevated intraabdominal pressure; (4) Management of AKI, including nutrition, anticoagulation, and dialysate composition; (5) Impact of renal replacement therapy on mortality and recovery. Results and Conclusions: The Jury recommended the use of newly described definitions. AKI significantly contributes to the morbidity and mortality of critically ill patients, and adequate volume repletion is of major importance for its prevention, though correction of fluid deficit will not always prevent renal failure. Fluid resuscitation with crystalloids is effective and safe, and hyperoncotic solutions are not recommended because of their renal risk. Renal replacement therapy is a life-sustaining intervention that can provide a bridge to renal recovery; no method has proven to be superior, but careful management is essential for improving outcome.
引用
收藏
页码:1128 / 1155
页数:28
相关论文
共 345 条
[1]  
Abassi ZA, 1998, SEMIN NEPHROL, V18, P558
[2]   The outcome of acute renal failure in the intensive care unit according to RIFLE: Model application, sensitivity, and predictability [J].
Abosaif, NY ;
Tolba, YA ;
Heap, M ;
Russell, J ;
El Nahas, AM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (06) :1038-1048
[3]  
*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801
[4]  
Agha-Razii M, 2000, CLIN NEPHROL, V54, P59
[5]   Prevention of renal impairment by continuous infusion of human atrial natriuretic peptide after liver transplantation [J].
Akamatsu, N ;
Sugawara, Y ;
Tamura, S ;
Kaneko, J ;
Togashi, J ;
Kishi, Y ;
Imamura, H ;
Kokudo, N ;
Makuuchi, M .
TRANSPLANTATION, 2005, 80 (08) :1093-1098
[6]   Terlipressin or norepinephrine in hyperdynamic septic shock:: A prospective, randomized study [J].
Albanese, Jacques ;
Leone, Marc ;
Delmas, Anne ;
Martin, Claude .
CRITICAL CARE MEDICINE, 2005, 33 (09) :1897-1902
[7]   Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2 [J].
Alessandria, C ;
Venon, WD ;
Marzano, A ;
Barletti, C ;
Fadda, M ;
Rizzetto, M .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2002, 14 (12) :1363-1368
[8]   Incidence and outcomes in acute kidney injury: A comprehensive population-based study [J].
Ali, Tariq ;
Khan, Izhar ;
Simpson, William ;
Prescott, Gordon ;
Townend, John ;
Smith, William ;
MacLeod, Alison .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (04) :1292-1298
[9]  
ALONSO A, 2002, COCHRANE DB SYST REV
[10]   Myoglobin clearance and removal during continuous venovenous hemofiltration [J].
Amyot, SL ;
Leblanc, M ;
Thibeault, Y ;
Geadah, D ;
Cardinal, J .
INTENSIVE CARE MEDICINE, 1999, 25 (10) :1169-1172